TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort

被引:1
作者
Ettleson, Matthew D. [1 ]
Penna, Gustavo C. E. [1 ]
Wan, Wen [2 ]
Bensenor, Isabela M. [3 ]
Laiteerapong, Neda [2 ]
Bianco, Antonio C. [1 ]
机构
[1] Univ Chicago, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA
[2] Univ Chicago, Sect Gen Internal Med, Chicago, IL 60637 USA
[3] Univ Sao Paulo, Clin Hosp, Ctr Clin & Epidemiol Res, Dept Med, BR-05508000 Sao Paulo, Brazil
基金
美国国家卫生研究院; 巴西圣保罗研究基金会;
关键词
hypothyroidism; levothyroxine; longitudinal analysis; cardiovascular outcomes; THYROID-STIMULATING HORMONE; BLOOD-PRESSURE; REFERENCE RANGE; UNDER-TREATMENT; UNITED-STATES; SERUM TSH; ASSOCIATION; HYPOTHYROIDISM; POPULATION; REPLACEMENT;
D O I
10.1210/clinem/dgae294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Thyroid-stimulating hormone (TSH) trajectory classification represents a novel approach to defining the adequacy of levothyroxine (LT4) treatment for hypothyroidism over time. Objective: This is a proof of principle study that uses longitudinal clinical data, including thyroid hormone levels from a large prospective study to define classes of TSH trajectories and examine changes in cardiovascular (CV) health markers over the study period. Methods: Growth mixture modeling (GMM), including latent class growth analysis (LCGA), was used to classify LT4-treated individuals participating in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) based on serial TSH levels. Repeated measure analyses were then utilized to assess within-class changes in blood pressure, lipid levels, hemoglobin A1c, and CV-related medication utilization. Results: From the 621 LT4-treated study participants, the best-fit GMM approach identified 4 TSH trajectory classes, as defined by their relationship to the normal TSH range: (1) high-high normal TSH, (2) normal TSH, (3) normal to low TSH, and (4) low to normal TSH. Notably, the average baseline LT4 dose was lowest in the high-high normal TSH group (77.7 mu g, P < .001). There were no significant differences in CV health markers between the classes at baseline. At least 1 significant difference in CV markers occurred in all classes, highlighted by the low to normal class, in which total and high-density lipoprotein cholesterol, triglycerides, and A1c all increased significantly (P = .049, P < .001, P < .001, and P = .001, respectively). Utilization of antihypertensive, antihyperlipidemic, and antidiabetes medications increased in all classes. Conclusion: GMM/LCGA represents a viable approach to define and examine LT4 treatment by TSH trajectory. More comprehensive datasets should allow for more complex trajectory modeling and analysis of clinical outcome differences between trajectory classes.
引用
收藏
页码:3065 / 3075
页数:11
相关论文
共 40 条
  • [31] Thyroid Hormone Therapy and Incident Stroke
    Papaleontiou, Maria
    Levine, Deborah A.
    Reyes-Gastelum, David
    Hawley, Sarah T.
    Banerjee, Mousumi
    Haymart, Megan R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (10) : E3890 - E3900
  • [32] Longitudinal Trajectories of Gestational Thyroid Function: A New Approach to Better Understand Changes in Thyroid Function
    Pop, Victor
    Broeren, Maarten
    Wijnen, Hennie
    Endendijk, Joyce
    van Baar, Anneloes
    Wiersinga, Wilmar
    Williams, Graham R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (08) : 2889 - 2900
  • [33] Thyroid Hormone Signaling and the Liver
    Ritter, Megan J.
    Amano, Izuki
    Hollenberg, Anthony N.
    [J]. HEPATOLOGY, 2020, 72 (02) : 742 - 752
  • [34] Levothyroxine overuse: time for an about face?
    Rodriguez-Gutierrez, Rene
    Maraka, Spyridoula
    Ospina, Naykky Singh
    Montori, Victor M.
    Brito, Juan P.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (04) : 246 - 248
  • [35] Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil)
    Schmidt, Maria Ines
    Duncan, Bruce B.
    Mill, Jose Geraldo
    Lotufo, Paulo A.
    Chor, Dora
    Barreto, Sandhi Maria
    Aquino, Estela M. L.
    Azeredo Passos, Valeria Maria
    Matos, Sheila M. A.
    Molina, Maria del Carmen B.
    Carvalho, Marilia S.
    Bensenor, Isabela M.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (01) : 68 - 75
  • [36] Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia
    Soldevila, Berta
    Velasco, Ines
    Munoz, Carla
    Diaz, Yesika
    Egea-Cortes, Laia
    Ferrer-Escopinan, Laura
    de Oca, Alejandra Perez-Montes
    Martinez-Mondejar, Raquel
    Casabona, Jordi
    Puig-Domingo, Manel
    [J]. EUROPEAN THYROID JOURNAL, 2023, 12 (05)
  • [37] High Frequency of and Factors Associated with Thyroid Hormone Over-Replacement and Under-Replacement in Men and Women Aged 65 and Over
    Somwaru, Lily L.
    Arnold, Alice M.
    Joshi, Neha
    Fried, Linda P.
    Cappola, Anne R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) : 1342 - 1345
  • [38] Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study
    Thayakaran, Rasiah
    Adderley, Nicola J.
    Sainsbury, Christopher
    Torlinska, Barbara
    Boelaert, Kristien
    Sumilo, Dana
    Price, Malcolm
    Thomas, G. Neil
    Toulis, Konstantinos A.
    Nirantharakumar, Krishnarajah
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 366
  • [39] Mechanistic Insights Into the Heterogeneity of Glucose Response Classes in Youths With Obesity: A Latent Class Trajectory Approach
    Trico, Domenico
    McCollum, Sarah
    Samuels, Stephanie
    Santoro, Nicola
    Galderisi, Alfonso
    Groop, Leif
    Caprio, Sonia
    Shabanova, Veronika
    [J]. DIABETES CARE, 2022, 45 (08) : 1841 - 1851
  • [40] Longitudinal Changes in Thyroid Function in the Oldest Old and Survival: The Cardiovascular Health Study All-Stars Study
    Waring, Avantika C.
    Arnold, Alice M.
    Newman, Anne B.
    Buzkova, Petra
    Hirsch, Calvin
    Cappola, Anne R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) : 3944 - 3950